McCormick, PA and Elrayah, E and Hughes, B and Schmidt, D and Moloney, J (2014) Letter: single liver stiffness measurement predicts liver-related mortality in chronic hepatitis C. Alimentary Pharmacology & Therapeutics, 39, (12), pp. 1438-1439. https://doi.org/10.1111/apt.12777.
External website: http://onlinelibrary.wiley.com/doi/10.1111/apt.127...
SIRS,
We read with interest the recent article on sofosbuvir signalling, a new era in treatment for patients with hepatitis C.[1] Intravenous drug use is the commonest mode of hepatitis C virus (HCV) transmission in Western countries, but treatment rates are very low.[2, 3] We hypothesised that liver stiffness measurement may help to identify high-risk patients and facilitate targeted treatment with the new oral antiviral agents.[4, 5] We measured liver stiffness (Fibroscan, Echosens) in a consecutive cohort of 84 patients attending a community-based drug treatment clinic and followed them up for 5 years.[6].....
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
G Health and disease > Digestive system disease > Liver disease
P Demography, epidemiology, and history > Population dynamics > Substance related mortality / death
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page